brain aneurysm: A congenital or acquired aneurysm within the cranium.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
268 |
4. Check minimum number of eventsNone |
268 |
5. Include endpointsNone |
268 |
6. Filter based on genotype QC (FinnGen only) |
268 |
Control definitions (FinnGen only)
- Control exclude
- I9_CEREBVASC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I67
- Name in latin
- Dissectio arteriae cerebralis sine ruptura
Similar endpoints
↥List of similar endpoints to
Dissection of cerebral arteries, nonruptured
based on the number of shared cases.
Similar with more cases:
- Cerebrovascular diseases
- Neurological diseases, wide definition
- Cardiovascular diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1673 | 729 | 931 |
| Only index persons | 1553 | 683 | 870 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.03 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 52.52 | 52.32 | 52.80 |
| Only index persons | 51.96 | 51.56 | 52.28 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 268 | 144 | 124 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | 50.75 | 47.98 | 53.98 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 244
- Matched controls
- 2441
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I67.0
ICD-10 Finland
Dissection of cerebral arteries, nonruptured
+∞
323.0
243
*
B01AA03
ATC
warfarin; systemic
14.7
70.9
141
207
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
839.6
67.3
63
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
751.9
61.6
58
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
31.5
46.6
62
26
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
+∞
40.8
38
*
AA1AD
NOMESCO Finland
CT of head and brain
7.5
40.7
118
270
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
+∞
36.4
34
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
+∞
34.2
32
*
G90.2
ICD-10 Finland
Horner syndrome
+∞
28.7
27
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
315.8
28.4
28
*
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
17.9
23.7
37
24
XA800
NOMESCO Finland
Neuropsychological investigation
15.4
21.8
36
27
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
21.1
20
*
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
+∞
20.1
19
*
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
216.9
19.9
20
*
B01AC04
ATC
clopidogrel; oral
4.8
14.9
53
133
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
7.4
14.8
36
56
K90
ICPC
Stroke/cerebrovascular accident
56.8
14.0
16
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
13.7
13
*
PA6CG
NOMESCO Finland
Extensive MRI examination of neck vasculature with high intensity magnet
147.9
13.6
14
*
XF400
NOMESCO Finland
ECG with 12 standard connections
4.1
13.4
56
164
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
15.2
13.0
21
15
R51.80
ICD-10 Finland
Headache
3.8
12.9
61
199
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
136.7
12.6
13
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.3
12.0
47
129
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.1
11.8
38
85
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.9
11.7
39
91
I65.0
ICD-10 Finland
Occlusion and stenosis of vertebral artery
+∞
11.5
11
*
C10AA05
ATC
atorvastatin; oral
2.7
11.1
102
516
PA6AD
NOMESCO Finland
CT of neck arteries
29.5
10.8
14
5
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
13.8
10.8
18
14
R4150
NOMESCO Finland
Neuropsychological rehabilitation
114.7
10.5
11
*
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
+∞
10.5
10
*
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
+∞
10.5
10
*
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
34.2
10.4
13
*
H53.1
ICD-10 Finland
Subjective visual disturbances
5.6
9.8
28
55
PA7BD
NOMESCO Finland
CT angiography of neck and brain
22.8
9.5
13
6
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
9.4
9
*
PA7CC
NOMESCO Finland
Very extensive angiography of arteries of neck and brain
+∞
9.4
9
*
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
10.1
8.9
17
18
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
12.2
8.7
15
13
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
10.6
8.7
16
16
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
13.4
8.5
14
11
B01AB05
ATC
enoxaparin; parenteral
2.4
8.5
88
463
I72.0
ICD-10 Finland
Aneurysm and dissection of carotid artery
+∞
8.4
8
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.0
8.4
33
91
C09AA05
ATC
ramipril; oral
2.6
7.6
63
291
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
82.5
7.5
8
*
K99
ICPC
Cardiovascular disease other
9.8
7.4
14
15
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
+∞
7.3
7
*
I10
ICD-10 Finland
Essential (primary) hypertension
2.1
7.3
132
880
R42
ICD-10 Finland
Dizziness and giddiness
2.5
7.1
58
267
N02BE01
ATC
paracetamol; systemic, rectal
2.6
7.0
213
1765
R4120
NOMESCO Finland
Occupational therapy
4.3
6.7
24
61
N03AF02
ATC
oxcarbazepine; oral
6.5
6.6
16
26
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
71.6
6.5
7
*
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
71.6
6.5
7
*
C10AA01
ATC
simvastatin; oral
2.1
6.3
91
545
H53.4
ICD-10 Finland
Visual field defects
13.0
6.1
10
8
ZXA05
NOMESCO Finland
Left side
2.2
6.0
68
363
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018677) aPTT in Platelet poor plasma by Coagulation assay
102
252
5.92
41.77
2.0
1.8
s
29.2
29.5
0.23
97
242
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
135
575
3.72
24.98
2.4
1.9
u/l
158.9
162.1
0.03
129
533
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
56
200
3.28
12.64
7.9
7.8
kpa
5.2
5.2
0.10
50
192
(3003396) Base excess in Arterial blood by calculation
56
200
3.28
12.64
7.4
7.9
mmol/l
1.0
1.4
0.31
39
165
(3027801) Oxygen [Partial pressure] in Arterial blood
56
200
3.28
12.64
7.9
7.8
kpa
13.4
12.0
0.71
50
194
(3032080) INR in Blood by Coagulation assay
131
763
2.40
11.17
10.2
7.7
inr
1.4
1.2
1.22
31
234
(3013826) Glucose [Moles/volume] in Serum or Plasma
179
1201
2.48
11.01
6.0
4.2
mmol/l
6.1
6.6
4.95
168
1117
(3022217) INR in Platelet poor plasma by Coagulation assay
56
225
2.88
10.20
25.5
18.3
inr
2.4
1.2
—
6
35
(3016502) Oxygen saturation in Arterial blood
48
185
2.94
9.39
6.9
8.3
%
95.6
96.0
0.16
42
180
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
24
6.56
9.09
1.1
1.1
u/ml
3.3
2.9
—
7
10
(3002173) Hemoglobin [Mass/volume] in Arterial blood
46
177
2.93
9.01
8.6
8.4
g/l
119.4
122.3
0.38
40
170
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
72
355
2.41
8.57
3.8
3.4
ng/l
382.2
228.4
0.34
48
259
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
7
16.30
7.29
1.6
2.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
28
91
3.32
7.25
7.2
10.6
mmol/l
24.6
25.0
0.29
28
82
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
33
121
2.97
7.00
7.3
8.9
%
0.7
0.7
0.09
33
121
(3019060) Gas panel - Arterial blood
32
119
2.92
6.62
4.9
4.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
33
4.76
6.54
1.3
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
233
1941
2.53
6.41
22.5
15.2
g/l
333.7
333.0
0.57
233
1933
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
138
955
1.92
6.37
8.6
6.2
mmol/l
1.2
1.2
1.05
116
809
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
39
165
2.60
6.33
3.3
2.7
ml/min/173m2
68.1
74.4
0.29
15
67
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
43
4.15
6.27
1.6
1.1
e6/l
38.7
9.7
0.36
12
33
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
127
865
1.89
6.07
7.8
5.2
mmol/l
1.2
1.2
1.22
114
793
(4306422)
11
20
5.69
5.85
1.1
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
31
122
2.74
5.78
7.4
8.6
%
1.7
1.5
0.27
31
122
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
10
17
6.07
5.67
1.1
1.1
%
100.6
93.8
—
10
17
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
60
323
2.10
5.59
2.9
2.5
e6/l
1.3
1.0
0.28
33
173
(36304419) Bacteria [Presence] in Urine
86
540
1.87
5.12
3.3
2.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
55
296
2.08
5.10
3.4
2.6
e6/l
3.4
3.0
0.06
29
149
(3008152) Bicarbonate [Moles/volume] in Arterial blood
28
113
2.65
4.98
9.6
7.1
mmol/l
24.1
24.4
0.18
22
107
(3018095) Leukocytes [#/volume] in Urine
104
704
1.78
4.80
4.4
3.2
e6/l
70.1
49.8
0.20
66
491
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
104
705
1.78
4.77
3.8
2.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
25
4.55
4.60
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
94
2.71
4.52
11.5
8.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
252
2265
2.89
4.41
19.7
13.3
mmol/l
4.0
4.0
0.27
246
2218
(3000991) Gas panel - Venous blood
32
147
2.34
4.36
9.8
8.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
251
2254
2.79
4.35
19.8
13.2
mmol/l
139.8
139.8
0.10
246
2208
(3030467) Casts [#/volume] in Urine by Automated count
83
545
1.76
4.15
3.5
2.7
e6/l
0.3
0.3
0.17
62
401
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
247
2216
2.46
4.02
17.6
12.0
mg/l
21.0
22.5
0.25
199
1699
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
69
434
1.79
3.98
2.1
2.0
mg/l
2.9
3.2
0.37
61
376
(3002582) Erythrocytes [#/volume] in Urine
88
595
1.71
3.94
3.9
2.8
e6/l
54.9
38.5
0.29
62
449
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
16
54
3.09
3.92
1.7
2.3
g/l
0.4
1.3
0.62
16
49
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
11
7.46
3.88
1.1
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
15
50
3.12
3.75
5.9
6.8
mmol/l
1.0
1.2
—
10
43
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
70
453
1.74
3.64
1.6
1.6
mg/l
0.6
1.0
1.90
49
353
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
9
7.95
3.58
1.1
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
185
1539
1.65
3.52
3.6
3.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
43
244
1.91
3.41
3.5
2.2
%
22.0
23.3
0.28
37
217
(3013707) Erythrocyte sedimentation rate by Westergren method
190
1599
1.65
3.37
4.3
3.8
mm/h
9.8
10.4
0.23
185
1484
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
72
481
1.68
3.31
2.8
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
38
212
1.92
3.17
2.2
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
14
50
2.90
3.14
1.6
2.0
g/l
38.2
39.0
0.20
14
43
(3003458) Phosphate [Moles/volume] in Serum or Plasma
41
236
1.87
3.11
8.5
5.0
mmol/l
1.0
1.0
0.08
36
219
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
37
206
1.92
3.10
2.1
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
16
5.12
3.07
1.4
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
51
2.84
3.03
2.7
2.8
—
—
—
0
0
(4268621)
8
17
4.82
2.94
2.3
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
74
513
1.61
2.91
3.4
2.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
73
505
1.61
2.89
4.3
4.1
—
—
—
0
0
(4027681)
7
13
5.50
2.88
1.4
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
67
454
1.63
2.88
4.1
3.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
9
6.79
2.88
1.2
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
9
6.79
2.88
1.0
1.0
%
120.8
154.7
—
6
9
(3012095) Magnesium [Moles/volume] in Serum or Plasma
49
306
1.74
2.85
2.6
3.0
mmol/l
0.8
0.8
0.51
43
295
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
65
2.55
2.85
1.7
1.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
61
408
1.64
2.76
2.8
2.3
e6/l
3.1
4.7
1.14
52
360
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
122
962
1.49
2.64
5.6
3.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
99
751
1.50
2.57
3.4
3.5
ng/l
42.1
39.2
0.04
60
477
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
7
7.25
2.56
1.2
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
59
402
1.60
2.46
1.3
1.3
iu/ml
38.6
32.4
0.17
19
137
(3020564) Creatinine [Moles/volume] in Serum or Plasma
254
2383
2.26
2.39
19.6
13.8
umol/l
81.1
76.0
0.78
254
2383
(3037522) Nuclear Ab [Titer] in Serum
46
298
1.66
2.34
1.5
1.4
titre
208.0
495.2
—
5
66
(40761535) Cells panel - Urine sediment
28
157
1.87
2.32
3.6
3.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
25
135
1.94
2.31
2.3
2.3
g/l
64.3
68.2
2.18
25
124
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
223
2019
1.62
2.30
5.0
4.4
mu/l
1.7
2.4
0.62
212
1861
(3043409) Potassium [Moles/volume] in Arterial blood
14
60
2.41
2.26
5.6
3.3
mmol/l
3.8
4.0
0.72
14
55
(3026782) Osmolality of Urine
55
378
1.57
2.21
2.7
2.4
mosm/kgh2o
499.8
574.1
1.73
43
328
(3004588) Protein electrophoresis panel - Serum or Plasma
21
109
2.01
2.17
1.7
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
240
2225
1.75
2.12
4.7
4.2
mmol/l
1.4
1.5
0.93
229
2071
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
180
1570
1.45
2.11
3.4
2.9
u/l
46.0
47.7
0.07
169
1491
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
234
2156
1.67
2.10
4.2
3.7
mmol/l
1.2
1.3
1.12
223
1996
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
242
1.66
2.07
9.4
6.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
84
640
1.46
2.07
3.4
2.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
20
3.56
2.07
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
166
1430
1.42
2.06
4.2
3.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
98
771
1.43
2.03
2.0
1.8
pmol/l
89.9
96.3
0.71
51
411
(3020891) Body temperature
16
77
2.15
2.01
6.4
3.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
64
2.25
1.98
1.3
2.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
45
303
1.58
1.97
2.2
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
16
3.81
1.94
1.2
3.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
106
853
1.40
1.91
5.5
4.5
g/l
35.8
36.3
0.44
99
803
(3007461) Platelets [#/volume] in Blood
260
2498
2.37
1.90
26.5
17.8
e9/l
247.1
252.0
0.62
253
2450
(3022621) pH of Urine by Test strip
21
115
1.90
1.89
2.0
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
243
2275
1.73
1.87
5.4
4.6
mmol/l
2.6
2.9
4.57
236
2115
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
186
1651
1.41
1.84
8.1
7.4
u/l
72.5
77.4
1.53
176
1563
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
12
4.22
1.83
1.4
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
73
933
0.70
1.82
2.4
2.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
239
2231
1.66
1.82
4.8
4.2
mmol/l
4.4
4.8
5.10
231
2090
(3010813) Leukocytes [#/volume] in Blood
260
2502
2.31
1.77
26.6
17.8
e9/l
7.1
6.6
0.60
251
2450
(3026361) Erythrocytes [#/volume] in Blood
260
2501
2.33
1.77
26.6
17.7
e12/l
4.5
4.5
0.03
250
2447
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
222
2042
1.51
1.76
5.5
5.3
mmol/mol
38.2
39.5
1.40
215
1930
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
61
2.19
1.74
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
61
2.19
1.74
1.0
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
27
165
1.71
1.72
6.6
3.0
mmol/l
2.4
2.3
0.05
18
130
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
13
3.90
1.72
1.0
1.4
g/l
0.9
1.2
—
5
13
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
42
2.43
1.69
1.1
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
36
239
1.58
1.68
1.5
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
62
2.15
1.68
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
248
2352
1.73
1.57
16.4
11.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
33
2.47
1.55
3.1
1.9
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
5
15
3.38
1.53
9.0
5.7
mg/l
14.6
11.5
—
5
15
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
51
2.21
1.52
1.2
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
124
1052
1.33
1.52
7.3
5.5
e9/l
0.6
0.6
0.35
110
929
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7
27
2.63
1.52
3.3
1.4
—
111.7
—
0
6
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
72
2.00
1.52
1.6
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
21
2.90
1.51
1.2
3.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
129
1102
1.33
1.51
5.7
6.3
umol/l
10.5
11.1
0.40
124
1055
(3017143) Hepatitis C virus Ab [Presence] in Serum
36
246
1.54
1.50
2.4
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
124
1055
1.33
1.48
7.3
5.6
e9/l
0.0
0.0
0.04
110
931
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
28
2.54
1.46
3.3
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
42
299
1.48
1.45
2.2
1.6
—
—
—
0
0
(3012544) pH of Venous blood
26
166
1.63
1.44
7.2
2.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
21
127
1.71
1.41
2.9
3.1
e9/l
90.6
71.5
1.68
11
96
(3019150) Specific gravity of Urine by Refractometry
58
442
1.40
1.40
4.8
3.5
kg/l
1.0
1.0
—
9
48
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
29
2.45
1.40
3.3
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
49
363
1.43
1.38
2.3
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
141
1234
1.30
1.33
9.5
9.4
e9/l
4.2
4.0
0.40
127
1090
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
34
2.39
1.30
2.0
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
48
2.13
1.29
1.7
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
11
55
2.04
1.29
2.1
2.4
mg/l
1.5
1.4
0.09
11
50
(3013115) Eosinophils [#/volume] in Blood
126
1091
1.29
1.27
7.3
6.0
e9/l
0.2
0.2
0.55
118
980
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
25
2.43
1.25
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
25
2.43
1.25
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
223
2091
1.40
1.23
19.5
12.4
%
39.9
40.7
0.62
177
1633
(3042936) Bacteria identified in Isolate by Culture
40
292
1.43
1.23
2.0
1.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
125
1086
1.28
1.22
7.3
5.5
e9/l
1.9
1.9
0.12
113
975
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
81
665
1.31
1.21
2.2
2.5
u/l
60.8
55.2
0.63
73
611
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
68
545
1.33
1.20
3.4
3.1
ng/l
1881.7
958.2
0.75
60
453
(3015377) Calcium [Moles/volume] in Serum or Plasma
82
677
1.30
1.17
2.7
3.4
mmol/l
2.3
2.3
0.30
74
606
(3026493) Urate [Moles/volume] in Serum or Plasma
68
547
1.33
1.17
2.8
2.5
umol/l
12982.8
6349.7
0.31
62
491
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
182
1663
1.29
1.17
4.2
3.8
pmol/l
14.6
14.7
0.05
174
1528
(3025941) Bacteria identified in Stool by Culture
19
119
1.64
1.15
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
224
2111
1.37
1.12
14.8
11.1
ml/min/173m2
83.9
84.3
0.12
193
1755
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
265
0.62
1.12
1.5
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
83
691
1.29
1.11
6.1
5.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
59
1.90
1.09
2.8
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
50
389
1.35
1.07
1.3
1.3
u/ml
1.2
10.4
2.12
13
164
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
90
1.71
1.06
1.7
2.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
87
733
1.28
1.06
3.5
3.2
u/l
33.4
31.9
0.16
82
699
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
46
1.99
1.04
1.8
1.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
55
438
1.32
1.02
1.5
1.4
nmol/l
18.3
20.9
0.76
50
380
(40768804) Tissue Pathology biopsy report
98
843
1.26
1.00
2.1
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
36
1.97
0.97
1.7
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
77
1.72
0.97
4.1
2.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
183
0.58
0.95
1.0
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
28
2.17
0.92
2.8
4.1
—
1096.2
—
0
6
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
28
2.17
0.92
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
28
2.17
0.92
1.7
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
29
2.09
0.90
1.0
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
109
960
1.23
0.88
12.6
8.8
e9/l
0.0
0.0
0.60
89
802
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
226
2153
1.32
0.87
4.6
4.2
mmol/l
5.8
5.9
0.54
214
1995
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
30
2.02
0.87
2.2
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
117
1039
1.22
0.87
4.0
3.2
estimate
0.0
0.0
0.50
14
202
(3018418) pH of Serum or Plasma
71
597
1.26
0.87
6.1
3.5
ph
7.4
7.4
0.78
12
113
(3035350) Ketones [Presence] in Urine by Test strip
115
1021
1.22
0.86
4.1
3.2
estimate
0.0
0.0
0.00
14
209
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
31
1.96
0.85
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
48
586
0.78
0.81
3.4
2.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
33
1.84
0.79
1.8
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
115
1.51
0.79
1.1
1.3
—
—
—
0
0
(4035726)
12
185
0.63
0.78
1.5
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
11
67
1.67
0.76
1.2
1.4
miu/ml
179.7
269.6
—
6
36
(3021601) Nitrite [Presence] in Urine by Test strip
115
1031
1.20
0.76
5.3
4.3
estimate
0.0
0.0
0.00
14
209
(3000494) Fungus identified in Specimen by Culture
32
247
1.34
0.75
1.7
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
43
348
1.28
0.72
1.6
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
135
1.44
0.71
1.3
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
41
1.73
0.70
1.0
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
62
527
1.23
0.69
8.5
7.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
61
1.66
0.69
1.4
1.5
—
—
—
0
0
(4094501)
9
59
1.54
0.69
1.3
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
136
1.43
0.69
1.1
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
27
1.87
0.69
1.6
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
148
1.38
0.61
2.9
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
52
1.55
0.60
2.8
1.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
54
1.50
0.58
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
82
1.49
0.55
1.5
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
125
1.38
0.55
2.5
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
67
590
1.18
0.53
1.5
1.7
mmol/l
1.3
1.4
0.74
57
510
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
164
1.30
0.48
1.1
1.2
iu/ml
138.8
155.2
—
8
74
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
30
246
1.25
0.48
2.4
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
176
0.73
0.47
4.8
3.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
39
330
1.21
0.47
1.5
1.7
nmol/l
1213.1
1163.0
0.13
34
258
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
49
1.44
0.46
1.9
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
104
1.37
0.44
2.5
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
49
428
1.18
0.43
1.3
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
34
1.48
0.40
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
61
1.32
0.40
1.5
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
66
595
1.14
0.39
1.5
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
66
1.38
0.39
1.1
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
26
216
1.23
0.38
2.2
1.9
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
36
1.40
0.38
2.0
1.8
%
13.4
13.2
—
5
36
(3037756) Immunofixation for Serum or Plasma
5
37
1.36
0.37
1.2
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
37
1.36
0.37
1.4
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
37
1.36
0.37
1.2
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29
245
1.21
0.37
1.6
2.3
umol/l
6.2
7.4
0.35
22
215
(3013512) EKG study
53
591
0.87
0.36
4.8
3.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
12
90
1.35
0.36
1.9
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
41
1.47
0.36
2.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
41
1.47
0.36
2.0
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
76
0.65
0.36
2.2
1.8
—
—
—
0
0
(3000492) Spirometry study
18
222
0.80
0.36
1.4
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
68
619
1.13
0.35
3.0
3.1
mmol/l
7.3
8.2
1.01
56
527
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
43
1.40
0.35
2.0
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
64
582
1.13
0.34
4.2
4.2
%
19.7
21.3
0.38
25
259
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.8
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
30
257
1.19
0.34
1.2
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
46
1.31
0.33
2.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
46
1.31
0.33
2.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
46
1.31
0.33
2.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
46
1.31
0.33
2.0
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
44
391
1.15
0.32
1.5
1.8
pmol/l
411.4
435.4
0.35
39
340
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
101
1.30
0.32
2.9
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
98
0.71
0.31
5.0
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
175
1.22
0.31
5.8
3.8
%
0.8
0.2
—
6
45
(3001019) Free T4 and TSH panel - Serum or Plasma
12
152
0.78
0.30
1.2
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
65
597
1.12
0.29
3.6
4.0
mg/mmol
8.2
9.0
0.07
39
377
(3012516) Albumin [Mass/volume] in Urine
62
568
1.12
0.29
3.1
3.2
mg/l
1214.6
176.0
0.42
41
370
(1002224) Polysomnography panel
10
128
0.77
0.27
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
24
206
1.18
0.27
2.9
3.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
235
0.84
0.27
1.4
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
22
188
1.19
0.26
6.1
3.6
%
0.8
1.0
—
6
53
(40768797) Stomach Pathology biopsy report
34
302
1.14
0.26
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
296
0.87
0.24
1.5
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
38
1.32
0.23
1.2
1.2
u/l
30.3
14.9
—
5
33
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
51
470
1.11
0.22
1.2
1.3
u/ml
0.5
2.2
1.25
11
140
(3029937) Albumin [Presence] in Urine by Test strip
59
548
1.10
0.22
5.1
3.5
estimate
0.0
0.0
0.68
14
204
(3014051) Protein [Presence] in Urine by Test strip
5
41
1.22
0.22
2.2
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
41
1.22
0.22
3.8
2.3
—
—
—
0
0
(3016750) Collection duration of Urine
0
11
0.00
0.21
0.0
2.4
—
524.2
—
0
6
(3017704) Immunofixation for Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
10
0.00
0.21
0.0
1.9
—
4.1
—
0
10
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
0.6
—
0
5
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(4198724)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
43
1.17
0.21
2.0
3.3
u/ml
15.2
35.6
—
5
43
(40768441) Liver Pathology biopsy report
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(4024509)
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
13
0.00
0.21
0.0
2.2
—
688.0
—
0
6
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
89
846
1.08
0.20
2.2
2.3
nmol/l
82.8
75.7
0.97
83
766
(3044242) Glucose [Moles/volume] in Arterial blood
0
14
0.00
0.20
0.0
6.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
49
1.23
0.20
2.5
3.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
90
1.23
0.19
2.6
2.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
20
175
1.15
0.19
1.6
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
7
58
1.21
0.18
1.7
2.1
ug/l
142.3
272.4
—
7
53
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
60
1.17
0.18
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
7
62
1.13
0.17
1.0
1.2
—
60.0
—
0
9
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
16
183
0.87
0.16
1.8
2.3
g/l
0.2
0.2
0.34
16
173
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
79
1.14
0.15
1.7
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
80
1.13
0.15
1.1
1.6
—
—
—
0
0
(4010399)
17
150
1.14
0.15
1.5
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
42
447
0.93
0.13
2.6
2.9
ug/l
0.6
0.7
0.41
21
283
(3000764) Benzodiazepines [Presence] in Urine
10
86
1.17
0.11
1.1
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
45
1.11
0.10
1.6
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
87
1.16
0.09
1.1
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
58
1.04
0.08
2.2
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
58
1.04
0.08
2.0
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
60
0.83
0.08
1.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
88
1.14
0.08
1.1
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
88
1.14
0.08
1.1
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
83
808
1.04
0.08
4.5
3.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
14
153
0.91
0.07
1.5
3.6
mmol/l
1.2
1.2
0.01
14
136
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
84
1.07
0.07
1.3
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
154
1519
1.03
0.07
3.8
3.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
88
1.02
0.07
2.9
3.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
75
731
1.04
0.07
4.4
4.6
ug/l
1.5
2.3
1.00
67
654
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
104
0.86
0.06
3.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
18
168
1.08
0.06
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
46
446
1.04
0.05
1.6
1.4
g/l
2.1
2.5
1.38
31
274
(3019225) pH of Specimen
18
169
1.07
0.05
2.1
3.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
239
1.05
0.04
2.2
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
25
239
1.05
0.04
1.4
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
109
1.01
0.00
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
52
519
1.00
0.00
6.0
4.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
107
1.03
0.00
1.1
1.0
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
13
127
1.02
0.00
2.7
2.5
u/ml
25.7
51.1
0.62
13
122
(3048689) Calprotectin [Mass/mass] in Stool
27
274
0.98
0.00
3.1
2.6
ug/g
53.0
96.2
2.12
21
221
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.7
—
0
6
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
56
0.89
0.00
1.0
1.3
—
1.7
—
0
10
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
64
0.94
0.00
1.0
1.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
0.9
—
0
6
(3006653) Thiamine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.8
—
121.8
—
0
8
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
7
69
1.01
0.00
1.0
1.2
—
—
—
0
0
(4034850)
8
82
0.97
0.00
17.6
6.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
54
0.92
0.00
1.0
1.3
—
2.0
—
0
7
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
222.7
—
0
7
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
7.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
5.4
—
44.8
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint I9_DISCER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_DISCER | 1.628 [1.22, 2.17] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.506 |
During the follow-up period (1.1.1998 — 31.12.2019), 89 out of 624 females with I9_DISCER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_DISCER | 1.389 [1.11, 1.74] | 0.004 |
| Birth year | 0.99 [0.98, 1.0] | 0.035 |
During the follow-up period (1.1.1998 — 31.12.2019), 128 out of 787 males with I9_DISCER died.
Mortality risk
Mortality risk for people of age
years, who have I9_DISCER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.099% | 0.298% |
| 5 | 0.878% | 1.694% |
| 10 | 2.544% | 4.33% |
| 15 | 4.874% | 8.115% |
| 20 | 8.809% | 14.239% |
Relationships between endpoints
↥Index endpoint: I9_DISCER – Dissection of cerebral arteries, nonruptured
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data